Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression

Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression

BackgroundCOVID-19 can show a variable course, from asymptomatic infections to acute respiratory failure and death. For efficient allocation of resources, patients should be stratified according to their risk for a severe course as early as possible.Methods135 hospitalized patients with COVID-19 pne...

Full description

Bibliographic Details
Main Authors: Christian Matthias Zobel, Werner Wenzel, Jan Philipp Krüger, Ulrich Baumgarten, Tobias Wagelöhner, Nino Neumann, Behruz Foroutan, Rico Müller, Annette Müller, Dominic Rauschning, Meike Schüßler, Lorenz Scheit, Felix Weinreich, Klaas Oltmanns, Franziska Keidel, Maria Koch, Sebastian Spethmann, Maximilian Schreiner
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Microbiology
Subjects:
SARS-CoV-2
neopterin
ARDS
cytokine release syndrome
mechanical ventilation
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1256210/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2023.1256210/full

Similar Items